TreeFrog Therapeutics
TreeFrog Therapeutics aims at making iPS-derived cell therapies safer, more efficient and more affordable.
3
Funding Rounds
$157.3m
Money raised
Funding
Funding series
Funding Series Analysis
The company TreeFrog Therapeutics has raised a total of $157.3m in funding over 3 rounds.
Key Insights:
- TreeFrog Therapeutics Series B round, September 2021: $75m
- TreeFrog Therapeutics September 2021 Funding Round: $75m
- TreeFrog Therapeutics May 2019 Series A Funding Round: $7.3m
TreeFrog Therapeutics Series B round, September 2021
$75m
TreeFrog Therapeutics September 2021 Funding Round
$75m
TreeFrog Therapeutics May 2019 Series A Funding Round
$7.3m
Industries
TreeFrog Therapeutics is active in the following industries: